Curant Health and the 2016 American College of Gastroenterology Annual Scientific Meeting
Curant Health and Johns Hopkins University present Project A.L.I.V.E. interim study results.
“Do you take your IBD medicine? Assessing the effect of a patient fulfillment model on medication adherence.”
Dr. Sharon Dudley-Brown, Principal Investigator, Assistant Professor of Medicine; Director of Clinical Services, Vickie Andros, PharmD. and Krystin Tran, PharmD.
Curant Health was proud to present study results to date with Dr. Sharon Dudley-Brown of Johns Hopkins at this year’s recent ACG 2016. First announced September 2014, Curant Health, provider of enhanced medication therapy management and specialty pharmacy services, is conducting a study with the Meyerhoff Inflammatory Bowel Disease Center of the Johns Hopkins University School of Medicine to “implement and evaluate the effectiveness of an Inflammatory Bowel Disease (IBD) Medication Therapy Management (MTM) patient fulfillment model compared to standard care in a large university hospital setting.”
The team is evaluating results at 30 days, 60 days, six months, nine months and 12 months from the initiation of the IBD MTM patient fulfillment model.
The study’s abstract is available here.
What are the study objectives?
To improve symptoms as measured by the Dudley IBD Symptom Questionnaire (DISQ) and quality of life as measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ)
- To decrease hospital readmission rates for patients with IBD
- To improve adherence rates for IBD therapy
- To assess smoking rates among these patients with IBD
Why is it important to look at MTM and its effects on adherence rates for patients with IBD?
Increasingly recognized in the healthcare community is the absence of long-run reports on CD or UC. Therefore, data on Adverse Drug Events (ADE’s), hospital readmissions, and long-run adherence rates among these patients is currently very limited. An integrated MTM platform will allow for tackling these issues and evaluating the impact on IBD patients’ clinical outcomes. Read more from IBD News Today.
- From Washington, DC to your clinic’s front door: what will we learn together at the 2018 340B Coalition Winter Conference? January 12, 2018
Now more than ever, 340B covered entities must ensure they are providing high value, critical ...
- Risky business at the 2018 J.P. Morgan Healthcare Conference December 18, 2017
What pharma can’t say about outcomes based contracts at JPMorgan 2018. Hint: It’s the “P” ...
- What we learned at FLACCOs 2017 November 1, 2017
Here’s a hint: It’s mostly about why ACO leadership should attend FLAACOs 2018.
CMS recently reported ...
- Improving the provision of value: FLAACOs 2017 October 12, 2017
By definition, accountable care organizations are the tip of the spear in the transition from ...
- Sharon Dudley-Brown on improving the standard of chronic care management for IBD patients October 6, 2017
Video: Positively impacting outcomes through pharmacist-led chronic care management for IBD patients.
Johns Hopkins Medicine and ...